What is the Inclusion Criteria for Ketamine Infusion Therapy?web_admin
Ketamine infusion therapy is a popular treatment for treatment-resistant depression. Almost 10 – 20 percent patients undergoing depressive state meet the criteria for treatment-resistant depression – TRD.
When you take the professional assistance of a reputed psychiatrist for infusions, you must fulfill the following inclusion criteria;
- Age of 18 years or older
- Must have failed minimum 3 antidepressant trials
- Depression severity along with duration or lack of response to conventional antidepressant should be clinically sufficient to call for ketamine treatment and not the remaining traditional options.
- Suicidal ideations should be of severity to demand ketamine therapy in an effort to obtain instant antidepressant response along with the reduction of other suicidal ideations.
- In addition to MDD, the affected person may have a concurrent psychiatric diagnosis. Such disorders should be of clinical nature or not too severe that would increase the concerns regarding behavioral or psychiatric risk while undergoing ketamine treatment.
- Presence of a responsible and mature person who can transport the patient and able to move to and from ketamine therapy. A person who would stay with the patient until next morning following every treatment session.
Determination of the inclusion criteria of a patient for ketamine treatment is usually made by the psychiatrist after reviewing patient’s case. The psychiatrist may also review the patient’s records or perform a psychiatrist evaluation of the sufferer to be sure of existing depressive condition.
Once a patient meets the inclusion criteria, he/she is then asked to complete information about the medical history. This information helps in assessing whether or not the patient is the right candidate for the treatment.
If you don’t meet the criteria, you might not be inducted to receive ketamine treatment. Instead, you will be advised to engage in other antidepressant treatment for depression.